Interpret microbiology susceptibility test results for novel antimicrobial agents relevant to the management, and monitoring of patients with multi-drug resistant infections
Describe the added spectrum of activity of novel gram-negative antibiotics
Clinical pharmacists are often challenged with antibiotic selection for patients infected with multi-drug resistant organisms. There have been numerous new and novel antibiotics that have received FDA approval over the last decade. Many of these agents are not included on routine antibiotic susceptibility testing panels in hospital-based microbiology labs. Collaboration between the clinical microbiology lab and pharmacy is integral to developing processes and pathways for performing susceptibility testing of novel antibiotics.
This is an accredited, livestreamed course offered by Harvard Medical School as part of the Contemporary Pharmacotherapy: Collaborative Clinical Explorations series. This course is targeted to pharmacists, pharmacy residents, physicians, physician assistants, clinicians, medical residents, nurses and nurse practitioners.
Select the Take Course button to view additional information on the course registration page.
Contact ceprograms@hms.harvard.edu with questions.
